Travere Therapeutics Inc (TVTX) Ownership

5.39 ↓0.06 (-1.10%)
As of April 25, 2024, 3:59pm EST.

Institutional Ownership

BlackRock Inc is the biggest individual institutional holder of Travere Therapeutics Inc (TVTX), owning a total of 7.9 million shares. Combined, the top 40 institutional holders of TVTX own 138.55% of the company with a total of 104.7 million shares.

In the latest ownership report on December 31st 2023, the top 40 institutional holders increased their combined ownership of TVTX by 10.6 million shares. 15 institutions bought 12,790,760 total additional shares and increased their ownership by an average of 102.32%. However 3 institutions sold 2,188,948 total shares and decreased their ownership by an average of 21.43%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of Travere Therapeutics increased by a net total of 10,601,812 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.405%3.729%7,917,860284,6552023-12-31
Armistice Capital, LLC9.703%-1.547%7,384,000-116,0002023-12-31
Deep Track Capital, LP9.685%0.000%7,370,00002023-12-31
Vanguard Group Inc7.247%18.162%5,515,143847,6852023-12-31
State Street Corporation7.033%21.776%5,352,345957,0882023-12-31
Macquarie Group Ltd6.238%1.604%4,746,77674,9172023-12-31
Morgan Stanley - Brokerage Accounts5.435%84.628%4,136,2901,895,9532023-12-31
Renaissance Technologies Corp4.049%54.505%3,081,0141,086,8922023-12-31
Goldman Sachs Group Inc3.918%97.178%2,981,4961,469,4092023-12-31
Rock Springs Capital Management LP3.642%53.310%2,771,446963,7042023-12-31
Deutsche Bank AG3.155%678.318%2,400,7672,092,3112023-12-31
Pictet Asset Manangement SA3.110%10.574%2,366,878226,3382023-12-31
Kynam Capital Management, LP2.628%108.877%2,000,0001,042,4982023-12-31
Bank of America Corp2.131%33.429%1,621,467406,2412023-12-31
Geode Capital Management, LLC2.000%5.629%1,521,73081,0862023-12-31
Finepoint Capital LP1.886%60.224%1,435,321539,5002023-12-31
Millennium Management LLC1.701%-61.395%1,294,586-2,058,7952023-12-31
Farallon Capital Management, L.L.C.1.438%302.921%1,094,000822,4832023-12-31
Emerald Advisers, LLC1.375%-1.335%1,046,149-14,1532023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
BlackRock Inc10.405%3.729%7,917,860284,6552023-12-31
Armistice Capital, LLC9.703%-1.547%7,384,000-116,0002023-12-31
Deep Track Capital, LP9.685%0.000%7,370,00002023-12-31
HHG PLC9.288%1.770%6,966,970121,1572023-06-30
Vanguard Group Inc7.247%18.162%5,515,143847,6852023-12-31
State Street Corporation7.033%21.776%5,352,345957,0882023-12-31
Macquarie Group Ltd6.238%1.604%4,746,77674,9172023-12-31
Morgan Stanley - Brokerage Accounts5.435%84.628%4,136,2901,895,9532023-12-31
Adage Capital Partners Gp LLC5.487%58.229%4,113,9621,513,9622023-03-31
RA Capital Management, LLC5.342%-19.059%3,984,681-938,2602022-12-31
Renaissance Technologies Corp4.049%54.505%3,081,0141,086,8922023-12-31
Goldman Sachs Group Inc3.918%97.178%2,981,4961,469,4092023-12-31
Rock Springs Capital Management LP3.642%53.310%2,771,446963,7042023-12-31
VR Adviser, LLC3.448%0.000%2,623,6772,623,6772023-09-30
Deutsche Bank AG3.155%678.318%2,400,7672,092,3112023-12-31
Pictet Asset Manangement SA3.110%10.574%2,366,878226,3382023-12-31
Woodline Partners LP2.862%106.726%2,150,5651,110,2692023-09-30
Orbimed Advisors, LLC2.824%21.430%2,118,100373,8002023-06-30
Kynam Capital Management, LP2.628%108.877%2,000,0001,042,4982023-12-31
Point72 Asset Management, L.P.2.381%0.000%1,785,9791,785,9792023-06-30
Jacobs Levy Equity Management, Inc.2.197%9.639%1,671,770146,9702023-09-30
Bank of America Corp2.131%33.429%1,621,467406,2412023-12-31
Geode Capital Management, LLC2.000%5.629%1,521,73081,0862023-12-31
Finepoint Capital LP1.886%60.224%1,435,321539,5002023-12-31
Avidity Partners Management LP1.761%0.000%1,323,0001,323,0002023-09-30
Millennium Management LLC1.701%-61.395%1,294,586-2,058,7952023-12-31
Sofinnova Ventures1.686%118.535%1,263,721685,4532023-03-31
Baker Bros Advisors LP1.643%-62.871%1,225,255-2,074,7542022-12-31
JPMorgan Chase & Co1.512%-7.262%1,134,151-88,8072023-03-31
Assenagon Asset Management SA1.464%-33.800%1,098,045-560,6442023-06-30
Farallon Capital Management, L.L.C.1.438%302.921%1,094,000822,4832023-12-31
Emerald Advisers, LLC1.375%-1.335%1,046,149-14,1532023-12-31
Great Point Partners LLC1.338%111.158%1,003,000528,0002023-03-31
LAURION CAPITAL MANAGEMENT LP1.314%17.965%984,961150,0002023-03-31
D. E. Shaw & Co LP1.293%-22.003%983,545-277,4592023-09-30
Citadel Advisors Llc1.220%-4.622%909,999-44,0952023-03-31
Nuveen Asset Management, LLC1.186%171.866%890,777563,1242023-06-30
Sio Capital Management, LLC1.178%0.000%884,770884,7702023-09-30
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND1.355%16.005%877,000121,0002022-12-31
Northern Trust Corp0.992%1.637%636,51410,2542022-06-30

Mutual Fund Ownership

SPDR® S&P Biotech ETF is the biggest individual fund holder of Travere Therapeutics Inc (TVTX), owning a total of 4 million shares. Combined, the top 40 mutual fund holders of TVTX own 60.59% of the company with a total of 45.6 million shares.

In the latest ownership report on February 29th 2024, the top 40 fund holders increased their combined ownership of TVTX by 12 thousand shares. 5 funds bought 108,325 total additional shares and increased their ownership by an average of 1.44%. However 5 funds sold 120,233 total shares and decreased their ownership by an average of 1.91%.

Overall this is a negative sign as the number of shares owned by the top 20 mutual funds holding Travere Therapeutics decreased by a net total of -11,908 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF5.301%1.904%4,033,63175,3602024-02-29
Aviva Investors GlConvtAbsRet I USD Acc3.192%-2.398%2,428,812-59,6832024-02-29
Vanguard Total Stock Mkt Idx Inv3.101%-1.011%2,359,420-24,1002024-02-29
iShares Russell 2000 ETF2.307%-0.016%1,755,251-2872024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.312%1.168%998,62211,5332024-02-29
iShares Russell 2000 Growth ETF0.788%2.356%599,74413,8042024-02-29
BlackRock Advantage Small Cap Core Instl0.734%-5.699%558,193-33,7332024-02-29
iShares Biotechnology ETF0.710%-0.448%540,256-2,4302024-02-29
Principal SmallCap Growth I Instl0.619%0.091%470,7364282024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C0.573%1.680%435,6857,2002024-02-29

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
SPDR® S&P Biotech ETF5.301%1.904%4,033,63175,3602024-02-29
Macquarie US Small Cap Core Equity4.741%0.000%3,607,77102023-12-31
Delaware Small Cap Core I4.685%-1.185%3,565,035-42,7362024-01-31
Aviva Investors GlConvtAbsRet I USD Acc3.192%-2.398%2,428,812-59,6832024-02-29
Vanguard Total Stock Mkt Idx Inv3.101%-1.011%2,359,420-24,1002024-02-29
Vanguard Instl Ttl Stck Mkt Idx Tr3.000%14.072%2,252,934277,9272023-03-31
iShares Russell 2000 ETF2.307%-0.016%1,755,251-2872024-02-29
Janus Henderson Global Life Sciences D2.076%5.073%1,557,04075,1762023-06-30
Janus Henderson Global Life Sciences2.076%5.073%1,557,04075,1762023-06-30
Janus Henderson US SMID Cap Growth2.053%0.000%1,539,74402023-06-30
Janus Henderson Triton D2.053%0.000%1,539,74402023-06-30
Janus Global Life Science A USD1.920%37.318%1,242,850337,7622022-12-31
Janus Selection Global Life Science AUSD1.638%2.075%1,228,43424,9692023-06-30
Janus Henderson Glb Life Scn I2 USD1.629%-1.552%1,221,756-19,2642023-08-31
Pictet Biopharmaceutical Mother1.432%39.489%1,089,600308,4652023-10-13
Vanguard Institutional Extnd Mkt Idx Tr1.312%1.168%998,62211,5332024-02-29
Vanguard Extended Market Index Investor1.194%-0.022%895,750-2012023-08-31
Biotech Growth Ord1.144%0.000%860,00002023-08-31
Invesco Pharmaceuticals ETF0.973%0.000%730,67102023-10-31
Fidelity Small Cap Index0.953%1.492%725,34510,6612023-12-31
HBM Healthcare Investments AG Ord0.952%0.000%724,19602023-12-31
Fidelity® Small Cap Index0.934%2.839%702,01719,3782023-10-31
Emerald Growth A0.918%107.351%698,168361,4592024-01-31
Janus Henderson Venture D0.900%0.000%675,12102023-06-30
Janus Henderson US Small Cap Growth0.900%0.000%675,12102023-06-30
Invesco Dynamic Pharmaceuticals ETF0.838%0.000%628,14602023-07-31
iShares Russell 2000 Growth ETF0.788%2.356%599,74413,8042024-02-29
BlackRock Advantage Small Cap Core Instl0.734%-5.699%558,193-33,7332024-02-29
iShares Biotechnology ETF0.710%-0.448%540,256-2,4302024-02-29
TIAA-CREF Quant Small-Cap Equity Instl0.705%75.605%536,350230,9202024-01-31
Vanguard Strategic Equity Inv0.670%48.566%509,538166,5672023-12-31
Vanguard Explorer Inv0.627%162.648%477,361295,6122023-12-31
Principal SmallCap Growth I Instl0.619%0.091%470,7364282024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C0.573%1.680%435,6857,2002024-02-29
CREF Stock R10.543%-0.299%407,023-1,2192023-08-31
Fidelity® Extended Market Index0.527%0.000%396,22002023-11-30
Fidelity Extended Market Index0.502%1.091%381,5964,1192024-01-31
Direxion Daily S&P Biotech Bull 3X ETF0.485%2.117%369,0867,6522024-02-28
Schwab US Small-Cap ETF™0.419%0.000%315,97302024-01-31
Fidelity® Select Biotechnology0.468%-19.462%300,428-72,6002022-11-30

Discussions

Please log in or register to share your thoughts.

SayMyName10/27/23 04:21pm

$TVTX the market is selling off

0 Like Report